Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study

Journal of Patient-Reported Outcomes

Table 7 Completion of measures over time

Measure, n (%)	Time 1 (Baseline)	Time 2 (D8, Cycle 2)	Time 3 (D8, Cycle 5)
Baseline Demographics	287
Youth FACT-GOG-Ntx	266	265	255
Parent-Proxy FACT-GOG-Ntx	280	278	264
Youth CHRIs-Global	259	258	249
Parent-Proxy CHRIs-Global	274	269	256
Any measure completed ^a	300 (97.1%)	297 (96.7%)	283 (92.8%)
Eligible	309	307	305

^aAt least one of the following was completed at that time period: Youth FACT/GOG-Ntx, Parent-Proxy FACT/GOG-Ntx, Youth CHRIs-Global, Parent-Proxy CHRIs-Global. Youth is for patients aged 11 to 21.9 years; parent-proxy is for youth aged 5 to 17.9 years